Scholar Rock (SRRK)
(Delayed Data from NSDQ)
$9.43 USD
-0.40 (-4.07%)
Updated Jun 6, 2024 04:00 PM ET
After-Market: $9.45 +0.02 (0.21%) 5:06 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Brokerage Reports
Scholar Rock Holding Corporation [SRRK]
Reports for Purchase
Showing records 101 - 120 ( 120 total )
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
3Q19 Financials; Preliminary TOPAZ Data up Next by YE19, More to Follow in 2020
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
FY18 Financials; SMA Ph 2 Initiation and AACR Updates Up Ahead
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Target, Engaged: ?015 Shows Latent Myostatin Increases, Ph 2 in SMA Up Next
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Gilead Can Smell What the Scholar Rock is Cooking
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Unclassified
Selloff Unwarranted, Doma Failure only Reinforces SRRK''s Value Proposition
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Scholar Rock Holding Corporation
Industry: Unclassified
Company: Scholar Rock Holding Corporation
Industry: Unclassified
Recent Developments Highlight Opportunity for SRK-015
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Scholar Rock Holding Corporation
Industry: Unclassified
Initiating at OUTPERFORM: Stopping Problems Before They Mature
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D